Analyst consensus rating
Sagimet Biosciences Analyst Rating: Strong Buy
SGMT is rated Strong Buy by 10 analysts with a $28.60 target. As of 2026-08-22.
Direct answer
Sagimet Biosciences's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $28.60.
Forecast evidence checked August 22, 2026.
Get free Sagimet Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.25
- Average price target
- $28.60
- High price target
- $56.00
- Low price target
- $8.00
- Low target gap
- -22%
- Target upside
- +179%
- High target gap
- +446.3%
- Target range width
- 468.3%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sagimet Biosciences?
Sagimet Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $28.60.
How far are Sagimet Biosciences's low and high targets from the recorded price?
The low target implies -22%, while the high target implies +446.3%.
How many analysts are included in Sagimet Biosciences's consensus?
The verified consensus includes 10 analysts.
How is Sagimet Biosciences's target upside or downside calculated?
The average target of $28.60 is divided by the recorded price of $10.25, then one is subtracted to produce +179%. This does not guarantee a future return.
When was Sagimet Biosciences's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.